Andrew Clear

6.3k total citations · 1 hit paper
54 papers, 3.1k citations indexed

About

Andrew Clear is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Andrew Clear has authored 54 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 22 papers in Immunology. Recurrent topics in Andrew Clear's work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Immune Cell Function and Interaction (13 papers). Andrew Clear is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Immune Cell Function and Interaction (13 papers). Andrew Clear collaborates with scholars based in United Kingdom, United States and Germany. Andrew Clear's co-authors include John G. Gribben, Alan G. Ramsay, Rewas Fatah, Maria Calaminici, Janet Matthews, John C. Riches, Tim Lister, Abigail M. Lee, Finlay MacDougall and Hemant M. Kocher and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Andrew Clear

52 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

2013 441 citations Andrew Clear, John C. Riches et al. profile →

Peers

Countries citing papers authored by Andrew Clear

Since Specialization

Citations

This map shows the geographic impact of Andrew Clear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Clear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Clear more than expected).

Fields of papers citing papers by Andrew Clear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Clear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Clear. The network helps show where Andrew Clear may publish in the future.

Co-authorship network of co-authors of Andrew Clear

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Clear. A scholar is included among the top collaborators of Andrew Clear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Clear. Andrew Clear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells 2025 ·Journal of Clinical Investigation ·(unknown), (unknown), (unknown), Elena Pontarini, (unknown), (unknown), Andrew Clear, Stefano Bombardieri, Kevin Y. Yip, Dinis Pedro Calado, Mark S. Cragg, Sonya James, Matthew Carter, Jessica Okosun, John G. Gribben, Tetyana Klymenko, (unknown)	0
2	CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma 2024 ·British Journal of Haematology ·Emil Kumar, Koorosh Korfi, Findlay Bewicke‐Copley, (unknown), James A. Heward, Thomas E. Witzig, (unknown), Stephen M. Ansell, (unknown), Andrew Clear, Alejo Efeyan, Michael R. Green, R. Siebert, Barrie Peck, Maria Calaminici, Jun Wang, Sonali M. Smith, Anne J. Novak, Jude Fitzgibbon, Jessica Okosun	1
3	PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. 2022 ·Figshare ·Annalisa D’Avola, Nathalie Legrave, Mylène Tajan, Probir Chakravarty, (unknown), Hamish W. King, Katarína Kľučková, Eric C. Cheung, Andrew Clear, (unknown), Lingling Zhang, Louisa K. James, James I. MacRae, John G. Gribben, Dinis Pedro Calado, Karen H. Vousden, John C. Riches	25
4	Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics 2021 ·Science Immunology ·Hamish W. King, Nara Orban, John C. Riches, Andrew Clear, Gary Warnes, Sarah A. Teichmann, Louisa K. James	137
5	Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice 2021 ·Cellular and Molecular Gastroenterology and Hepatology ·Francesca Romana Delvecchio, (unknown), (unknown), Andrew Clear, Marina Roy-Luzarraga, Frances R. Balkwill, John G. Gribben, Stefano Bombardieri, Kairbaan Hodivala‐Dilke, Melania Capasso, Hemant M. Kocher	75
6	Antibody Repertoire and Gene Expression Dynamics of Diverse Human B Cell States During Affinity Maturation 2020 ·SSRN Electronic Journal ·Hamish W. King, Nara Orban, John C. Riches, Andrew Clear, Gary Warnes, Sarah A. Teichmann, Louisa K. James	1
7	Association of Low Tumor Endothelial Cell pY397–Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer 2020 ·JAMA Network Open ·Marina Roy-Luzarraga, Tarek M. Abdel-Fatah, Louise E. Reynolds, Andrew Clear, Joseph Taylor, John G. Gribben, Stephen Chan, J. Louise Jones, Kairbaan Hodivala‐Dilke	10
8	Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation 2019 ·Cell Reports ·(unknown), (unknown), Sayka Barry, Ezra Aksoy, (unknown), Anna Vossenkämper, Melania Capasso, Xinyu Wan, (unknown), Jennifer L. Marshall, Andrew Clear, John G. Gribben, Thomas T. MacDonald, Christopher D. Buckley, Márta Korbonits, Oliver Haworth	21
9	Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin 2018 ·Haematologica ·(unknown), Bola S. Hanna, Angela Schulz, Fabienne Lucas, Manuela Zucknick, Axel Benner, Andrew Clear, S. Öhl, Selcen Öztürk, Thorsten Zenz, Stephan Stilgenbauer, Min Li‐Weber, Peter H. Krammer, John G. Gribben, Peter Lichter, Martina Seiffert	32
10	Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma 2016 ·Clinical Cancer Research ·Steffen Böhm, Anne Montfort, Oliver M.T. Pearce, Joanne Topping, Probir Chakravarty, (unknown), Andrew Clear, (unknown), Darren Ennis, Thomas Dowe, Amanda Fitzpatrick, Elly Brockbank, Alexandra Lawrence, Arjun Jeyarajah, Asma Faruqi, Iain A. McNeish, Naveena Singh, Michelle Lockley, Frances R. Balkwill	111
11	Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy 2014 ·Nature ·Bernardo Tavora, Louise E. Reynolds, Sílvia Batista, Fevzi Demircioglu, Isabelle Fernandez, Tanguy Lechertier, Delphine M. Lees, Ping‐Pui Wong, Annika N. Alexopoulou, George Elia, Andrew Clear, Adeline Ledoux, Jill V. Hunter, Neil D. Perkins, John G. Gribben, Kairbaan Hodivala‐Dilke	134
12	Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP 2014 ·Haematologica ·Rita Coutinho, Andrew Clear, Emanuele Mazzola, Andrew Owen, Paul Greaves, Andrew Wilson, J. Matthews, Alexander Lee, Ricardo Alvarez, María Gomes da Silva, José Cabeçadas, Donna Neuberg, Mariarita Calaminici, John G. Gribben	48
13	Poor Concordance among Nine Immunohistochemistry Classifiers of Cell-of-Origin for Diffuse Large B-Cell Lymphoma: Implications for Therapeutic Strategies 2013 ·Clinical Cancer Research ·Rita Coutinho, Andrew Clear, Andrew Owen, Andrew Wilson, Janet Matthews, Abigail Lee, (unknown), María Gomes da Silva, José Cabeçadas, Maria Calaminici, John G. Gribben	83
14	Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation 2013 ·Journal of Clinical Oncology ·Shahryar Kiaii, Andrew Clear, Alan G. Ramsay, Derek Davies, Ajanthah Sangaralingam, Abigail Lee, Maria Calaminici, Donna Neuberg, John G. Gribben	80
15	Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma 2013 ·Blood ·David Wrench, Hasan Rizvi, Andrew Wilson, Ciarán Ó’Riain, Andrew Clear, Janet Matthews, Daniele Laszlò, T. Andrew Lister, John G. Gribben, Maria Calaminici, Silvia Montoto	2
16	Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome 2012 ·Journal of Clinical Oncology ·Paul Greaves, Andrew Clear, Rita Coutinho, Andrew Wilson, Janet Matthews, Andrew Owen, Milensu Shanyinde, Tim Lister, Maria Calaminici, John G. Gribben	120
17	Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment 2010 ·Blood ·Andrew Clear, Abigail M. Lee, Maria Calaminici, Alan G. Ramsay, Kelly J Morris, Simon Hallam, Gavin Kelly, Finlay MacDougall, Tim Lister, John G. Gribben	98
18	A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma 2005 ·Leukemia ·Andrew Davies, (unknown), Claire Taylor, Andrew Clear, Lindsey K. Goff, Sameena Iqbal, Darren Heavens, Mariarita Calaminici, A. J. Norton, T. Andrew Lister, Jude Fitzgibbon	50
19	Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on Tissue Microarray (TMA) of Diagnostic Lymph Nodes (LN). 2005 ·Blood ·Lindsey K. Goff, Abigail M. Lee, Andrew Clear, Maria Calaminici, Andrew Davies, Suzanne Jordan, Finlay MacDougall, Janet Matthews, A. J. Norton, John G. Gribben, T. Andrew Lister	1
20	Tissue Microarray Is a Useful Tool in the Evaluation of Genes Implicated in Transformation of Follicular Lymphoma. 2004 ·Blood ·Abigail Lee, Andrew Davies, Andrew Clear, Maria Calaminici, Janet Matthews, A. J. Norton, George W. Wright, Louis M. Staudt, Jude Fitzgibbon, T. Andrew Lister, Lindsey K. Goff	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact